Status:
RECRUITING
Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyotrophic Lateral Sclerosis
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease that occurs in adults. It is characterized by a progressive degeneration of the first and second motor neurons leading to muscle fai...
Eligibility Criteria
Inclusion
- Patient with Amyotrophic Lateral Sclerosis
- Certain or probable according to the revised Escorial criteria
- no indication for non-invasive ventilation
- Adult patient
- Patient who has given oral consent
- Patient who speaks and reads French
Exclusion
- Patients with pre-existing diaphragmatic dysfunction requiring non-invasive ventilation
- Person who is not affiliated to national health insurance
- Person subject to a legal protection measure (curatorship, guardianship)
- Patients deprived of their liberty
- Pregnant, parturient or breastfeeding women
Key Trial Info
Start Date :
May 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05352958
Start Date
May 16 2023
End Date
November 1 2028
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourogne
Dijon, France, 21000